PMVP - PMV Pharmaceuticals, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
PMV Pharmaceuticals, Inc.
IPO Date: September 25, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $80.19M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.43 | 3.66%
Avg Daily Range (30 D): $0.07 | 4.94%
Avg Daily Range (90 D): $0.05 | 4.07%
Institutional Daily Volume
Avg Daily Volume: .45M
Avg Daily Volume (30 D): .96M
Avg Daily Volume (90 D): .52M
Trade Size
Avg Trade Size (Sh.): 119
Avg Trade Size (Sh.) (30 D): 214
Avg Trade Size (Sh.) (90 D): 214
Institutional Trades
Total Institutional Trades: 878
Avg Institutional Trade: $2.32M
Avg Institutional Trade (30 D): $.56M
Avg Institutional Trade (90 D): $.56M
Avg Institutional Trade Volume: .16M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.22M
Avg Closing Trade (30 D): $.58M
Avg Closing Trade (90 D): $.58M
Avg Closing Volume: 149.19K
 
News
Sep 1, 2026 @ 3:03 AM
PMV Pharma Announces Pricing of Oversubscribed $50...
Source: Na
Apr 22, 2026 @ 12:00 PM
PMV Pharmaceuticals Announces Board Chair Transiti...
Source: Na
Mar 6, 2026 @ 1:00 PM
PMV Pharmaceuticals Reports Full Year 2025 Financi...
Source: Pmv Pharmaceuticals, Inc.
Jun 3, 2024 @ 1:55 PM
Here's Why PMV Pharmaceuticals (PMVP) Could be Gre...
Source: Zacks Equity Research
May 29, 2024 @ 11:00 AM
Foundation Medicine and PMV Pharma Announce Collab...
Source: PMV Pharmaceuticals, Inc.
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.42 $-.34 $-.34
Diluted EPS $-1.42 $-.34 $-.34
Revenue $4.48M $.79M $.98M
Gross Profit
Net Income / Loss $-75.22M $-18.09M $-18.04M
Operating Income / Loss $-79.66M $-18.88M $-19.02M
Cost of Revenue
Net Cash Flow $-31.66M $-25.52M $M
PE Ratio